Cancer Gene Therapy
Estrogen Receptor Activity Modulated by Genetic Manipulation
Published in Cancer Weekly, March 14th, 2000
"Successful endocrine therapy in breast cancer is frequently characterized by effective pharmacological suppression of tumor ER protein activity," wrote T.A. Madden et al. "To ascertain if a genetic approach could be similarly effective in downregulating the activities of the ER, we have transfected ER positive, MCF-7 cells, and ER negative but ER transfected COS-7 cells with: 1) chimeric methylphosphonate phosphodiester antisense oligonucleotides (ODNs) complementary to the 5' end of human ER mRNA; 2) two ER antisense RNA expression vectors containing 1.1kb or 1.8kb coding...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2000-03-14)
More Articles from Cancer Weekly
- Brain Cancer
Cannabinoids Tested Against Gliomas in Rats; Model Questioned by Some Researchers - Cancer Gene Therapy
Down-Regulation of GD3 Ganglioside Slows Melanoma Progression - Cancer Immunotherapy
Retrovirally Transduced Mouse DCs Require CD4+ T-Cell Help - Cancer Vaccines
Anti-Idiotype Antibody Vaccine Mimics Disialoganglioside GD2 - Chronic Myelogenous Leukemia
Thrombopoietin and Its Receptor Not Involved In Disease Progression - Chronic Myeloid Leukemia
Chromosome Deletions Non-Randomly Over-Represented - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
